Healthpeak reports Q2 2026 results and raises guidance
Net income of $0.08 per share and FFO as Adjusted of $0.46 per share; full-year 2026 guidance raised by $0.02 per share.
See the latest news and media coverage for Healthpeak. We track all announcements, press releases, and industry mentions in real time, all in one place.
Healthcare real estate investment trust
healthpeak.comLast updated
In short: Healthpeak raised its 2026 FFO guidance and completed several major transactions, including the $878 million Janus Living IPO.
Net income of $0.08 per share and FFO as Adjusted of $0.46 per share; full-year 2026 guidance raised by $0.02 per share.
Todd Meek served as SVP – Asset Management for nearly two decades and was known for his steady leadership and generosity.
The joint venture involves a portfolio of 86 outpatient medical buildings across 11 states. Healthpeak retains 51% controlling interest.
The board declared a monthly dividend of $0.10167 per share, annualized to $1.22 per share.
Healthpeak is an investment-grade, income and growth idea with a large-scale portfolio of outpatient, lab, and senior properties. See why DOC stock is a Buy.
04/08 (DOC) Healthpeak Properties expects adjusted FFO between $1.73 and $1.77 for 2026, compared to a FactSet consensus of $1.74 MT 04/08 Results overview: Healthpeak...
Investors in Healthpeak Properties, Inc. DOC need to pay close attention to the stock based on moves in the options market lately. That is because...
Healthpeak (DOC) Q2 2026 earnings call recap: raised FFO guidance, Brookfield/Blackstone JVs, leasing & lab recovery outlook.
Track Healthpeak and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Healthpeak and other trending companies.